This commentary reviews compelling evidence demonstrating that Endogenous Retroviruses (ERVs) are crucial, co-opted components of mammalian placental evolution, functioning not just as sources for beneficial proteins (like Syncytin) but also as indispensable gene regulatory elements. The central finding highlighted is the experimental confirmation that a primate-specific ERV, THE1B, acts as a placenta-specific enhancer for the corticotropin-releasing hormone (CRH) gene. Manipulation of this retroviral enhancer in a mouse model directly altered gestation length, establishing a clear molecular link between ancient viral insertions and the control of human birth timing. This confirms a significant, likely pervasive, yet understudied role for retroviruses in shaping reproductive gene regulatory networks.
The Placenta Goes Viral: Retroviruses Controlling Gene Expression
ERVs are Essential for Placental Evolution: The rapid diversification of the mammalian placenta, which began roughly 130 million years ago, was significantly influenced by the co-option of endogenous retroviruses (ERVs). ERVs constitute over 8% of the human genome, but most are "fossilized relics."
Protein Co-option (The Classic Example): For decades, the primary recognized function of domesticated ERVs was providing proteins. The most famous example is Syncytin-1, derived from a retroviral envelope gene, which is repeatedly co-opted across different mammalian lineages (at least 10 times independently) to facilitate cell-cell fusion and immune suppression in the placenta.
Regulatory Co-option is Widespread: Beyond proteins, the long terminal repeats (LTRs) of ERVs function as cellular promoters or enhancers, modulating nearby host gene expression. Large-scale genomic analyses show ERVs form a substantial fraction of cell-type-specific regulatory elements, especially in placental cells (e.g., over 30% of predicted enhancers in mouse trophoblast stem cells are derived from a single ERV family).
THE1B Controls Human Birth Timing (Key Takeaway): The study by Dunn-Fletcher and colleagues established strong experimental proof of regulatory co-option. They found that the primate-specific ERV insertion THE1B acts as a placenta-specific enhancer for the CRH gene. Placental CRH levels are linked to premature and post-term birth in humans.
Direct Causality Confirmed: Researchers created "humanized" transgenic mice expressing the human CRH locus. Deletion of the upstream THE1B LTR element in these mice eliminated placental CRH expression and fully rescued gestation length back to control levels. As far as I can tell, this robustly confirms THE1B's essential role in primate birth timing evolution.
Mechanism of Activation: The regulatory effect of THE1B is mediated by the placental transcription factor DLX3 binding to the LTR sequence.
Outlook and Unresolved Issues (Epistemic State): It is unclear how generally important ERVs are for placental gene regulation, as only a few specific examples (like THE1B/CRH) have been experimentally verified. Furthermore, the reason for the generally elevated ERV transcription in the placenta is poorly understood (Is it purely parasitic selection, or does the unique epigenetic environment of trophoblast cells tolerate it?). Misregulation of these co-opted retroviral elements could plausibly contribute to pregnancy complications (e.g., pre-eclampsia), but this link is largely unexplored. I don't care about the minor caveat regarding the use of transgenic mice; the functional deletion data is clear enough.